6Haeke W. Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet, 2004, 363:768- 774. 被引量：1
7Davis SM, Donnan GA, Parsons MW, et al. Effects of aheplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol, 2008, 7:299-309. 被引量：1
8Hacke W, Albers G, AI-Rawi Y, et al. The Desmoteplase In Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9- hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke, 2005, 36:66-73. 被引量：1
9Hacke W, Furlan A J, AI - Rawi Y, et al. Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo- controlled study. Lancet Neurol, 2009, 8:141-150. 被引量：1
10Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute isebaemic stroke (SITS-ISTR): an observational study. Lancet, 2008, 372:1303-1309. 被引量：1
